Emory University School of Medicine

Slides:



Advertisements
Similar presentations
Radial versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome the RIFLE STEACS study Enrico Romagnoli, MD PhD Principal investigators:
Advertisements

on behalf of the TOTAL Investigators
ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs. Everolimus-Eluting Stents for Treatment of Unprotected Left Main Coronary Artery Lesions Julinda Mehilli,
Template Title Speaker Name Subtitle. Disclosure Statement of Financial Interest Grant/Research Support Consulting Fees/Honoraria Major Stock Shareholder/Equity.
Improving outcome of STEMI PCI: Preliminary Results of Crystal AMI trial Rajesh M. Dave, MD Principal investigator on behalf of Crystal AMI Investigators.
Unresolved issues with Drug-eluting Stents Stent Thrombosis Advanced Angioplasty 2007 Dan Blackman Yorkshire Heart Centre.
Featuring CTO Complex-PCI by Trans-radial Approach CTO Case review 5 French TRI CTO of right coronary artery -5 F Launcher guiding Catheter (right Judkins.
Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients with Stable Coronary Disease: Results from the FAME.
Treatment of bifurcation lesions is a complex problem Different techniques are commonly used (Y-/T-stenting, „culotte“ technique, „kissing stent“ technique…)
New strategies and perfusion/aspiration devices for primary PCI Sandra Garcia Cruset, PhD. Cordynamic B.U. Marketing Manager.
Title of Presentation Presenter Name, Designation Presenter 2 Name, Designation Presenter 3 Name, Designation.
CIT 2016 Template Title 40 pt Bold Arial David Liu, MD Subtitle 34 pt Arial Bold Italics.
Complications of Percutaneous Coronary Intervention John S. Douglas Jr. MD Professor of Medicine Emory University School of Medicine SCAI International.
Northeast Georgia Heart Center Interventional Complications: State of the Art Review J. Jeffrey Marshall, MD, FSCAI Past President SCAI, Director.
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Strategies to Improve Inadequate Guide Catheter Support John S Douglas Jr MD S Tanveer Rab MD Emory University School of Medicine Atlanta Georgia Sunday.
Effect of Thrombus Aspiration in Patients With Myocardial Infarction Presenting Late After Symptom Onset Steffen Desch, MD Thomas Stiermaier, MD; Suzanne.
Philippe Généreux, MD for the Tryton Bifurcation Trial Investigators Columbia University Medical Center Cardiovascular Research Foundation New York City.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Final 5 year results from the all-comer COMPARE trial: a prospective randomized comparison between Xience-V and Taxus Liberté TCT 2013 San Francisco Pieter.
Intravascular ultrasound (IVUS) in percutaneous coronary intervention – summary of key articles While angiography is routinely used for assessment of CAD,
Intravascular ultrasound (IVUS) in the treatment of long and diffuse lesions– summary of key articles Prepared by Radcliffe Cardiology 21 November2016.
My Best Radial Case of the Past Year ... And what I learned from it
David E. Kandzari, MD on behalf of the BIONICS investigators
Disclosure Statement of Financial Interest
Clinical Trials and Outcomes with DES in CTO Revascularization
G. Capretti, M. Carlino, A. Colombo, L. Azzalini
Alaa gabi, md sUPERVISOR: RAMEEZ SAYYED, MD.
Disclosure Statement of Financial Interest
What´s New in the Literature on Transradial Intervention
Updates From NOTION: The First All-Comer TAVR Trial
Carotid Artery Stenting Predictors of procedural and clinical success
CRT 2017 Interventional Challenging Case Anterior ST- Elevation Myocardial Infarction Resulting From Acute Occlusion of Left Internal Mammary Artery Graft.
Procedural factors associated with PCI-related ischemic stroke
Medtronic Cardiovascular,
Coronary bifurcation wide-neck aneurysm successfully treated by provisional Y-stent-assisted coil embolization Gregory A. Sgueglia, MD, PhD Interventional.
Disclosure Statement of Financial Interest
The Tryton Bifurcation Trial:
Complex PCI to CTO lesion in RCA with nightmares complications
Subintimal Tracking and Reentry for CTO STAR Method
FAVOR II Europe-Japan FAVOR II E-J
OCT-Guided PCI What needs to be done to establish criteria?
Transradial Intervention as Access of Choice in STEMI
Essesntials for CTO Recanalization
S.G. Worthley, MB, BS, PhD., S. Redwood, MD, PhD.,
TRANSCATHETER MITRAL VALVE IMPLANTATION FOR SEVERE MITRAL REGURGITATION: THE TENDYNE GLOBAL FEASIBILITY TRIAL 1 YEAR OUTCOMES David WM Muller, MBBS,
Mortality Related to Periprocedural MI in CTO-PCI
The Hidden Cost of Underutilizing PCI for Chronic Total Occlusions
No Reflow Reflow P value Arrhythmia 40% 18% Lecture Notes
Cath Lab Catastrophes : Prevention & Management Strategies
Using Coronary CTA to Guide Intervention for CTO
CIT 2018 Template Title 40 pt Bold Arial
CIT 2018 Template Title 40 pt Bold Arial
CIT 2017 Template Title 40 pt Bold Arial
Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-year Outcomes of the EVERBIO.
Impact of clopidogrel loading dose on the safety and effectiveness of bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction:
CIT 2018 Template Title 40 pt Bold Arial
CIT 2017 Template Title 40 pt Bold Arial
Impact of Platelet Reactivity Following Clopidogrel Administration
Bifurcation Disease: Simulation Training Curriculum
Significance of Periprocedural Myocardial Infarctions in Percutaneous Coronary Interventions A New Look at an Old Topic Abhiram Prasad, MD, FRCP, FESC,
CIT 2017 Template Title 40 pt Bold Arial
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
CHRONIC TOTAL OCCLUSIONS: WHAT IS KNOWN AND
TAXUS – Myonecrosis and sidebranch patency concerns are short-term issues with no long-term consequences, and the benefits are undeniable Jeffrey J. Popma,
CIT 2017 Template Title 40 pt Bold Arial
Maintenance of Long-Term Clinical Benefit with
Disclosure Statement of Financial Interest
Disclosure Statement of Financial Interest
CIT 2018 Template Title 40 pt Bold Arial
Presentation transcript:

Emory University School of Medicine Complications of PCI : Perforation Requiring Pericardiocentesis , Device Embolization and Snares SCAI Fall Fellows Course 2012 John S. Douglas Jr. MD Professor of Medicine Emory University School of Medicine

Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below. Affiliation/Financial Relationship Company Consulting Fees/Honoraria None Major Stock Shareholder/Equity None Royalty Income None Ownership/Founder None Intellectual Property Rights None Other Financial Benefit None

Complications of Percutaneous Coronary Intervention Coronary Perforation Stent Misadventures Snares; other retrieval strategies

Coronary perforation during PCI in the IIb/IIIa Era Cleveland Clinic 5,500 Patients; 31% Abciximab; 9 Deaths 24% 30 P=0.02 No Abciximab % Abciximab 6% 1.3 1.5 Perforation Death J Am Coll Cardiol 1999; 33, 72A

Coronary Perforation Classification Type 1 Crater extending outside lumen only Type 2 Pericardial or myocardial blush without > 1mm exit hole Type 3 Contrast jet through > 1mm exit hole Ellis et al. Circulation 1992; 88: I-787

Causes of Coronary Perforation During PCI 1995-1999 at Christ Hospital 36 Perforations 15 Odds Ratio Perf. 16 Type 3 Perf. 29 10 Number of Patients 5 Guide Wire Balloon Stent Rotablater DCA Laser/TEC Dippel et al. Cathet Cardiovasc Intervent 2001; 52:279-286

Risk associated with Type 3 Perforation Ellis et al. 1992 Dippel et al. 2001 Tamponade 63% 43% Surgery 75% 50% QMI 29% Death 14% 21%

Cardiac Tamponade Complicating PCI – An 8 year experience at William Beaumont Hospital 36 Patients 60 56 44 42 39 % 29 In-Lab Out-of-Lab Surgery MI Death (mean 5 hours) Fejka et al. Circulation 2001; 104: II-417

Type III Coronary Perforation : 56 Cases From The Stent Era (1993-2009 ) Incidence : 56 of 24,465 ( 0.23%) Independent predictors were complex lesion , CTO , rotablation , and IVUS guidance Device implicated : balloon 50% , guidewire 18% , atheroablation 7.2% Treatment strategy : balloon 60% , covered stent 46% , coil 1.8% , multiple methods 39% Al-Lamee et al J Am Coll Cardiol Intv 2011;4 :87-95

Outcomes Following Type III Perforation Tamponade & pericardiocentesis in 29% CPR was required in 20% ; IABP in 20% MI ( 3 X CK-MB ) in 43% In – hospital MACE in 55% ; death in 18% Outcomes with GPI were worse (MI 70% , CABG 30% , death 22% and MACE in 90% ) Stent thrombosis in 8.6% of covered stents Al-Lamee et al J Am Coll Cardiol Intv 2011;4 :87-95

Small “Stain” Noted on the Inferior Wall During RCA Stent Procedure Reopro Discontinued

Tamponade 3 hrs later: Balloon Occlusion Sealed Perforation Only After Distal Platelet Injection

PCI of Chronic Total Occlusion Difficult Wire Passage

Type 3 Perforation Following Inflation of 1.5mm Balloon

Type 3 Perforation Treated with Coil Embolization

Coronary Perforation - Diagnosis - Angiographic (blush, jet, coronary sinus compression, contrast in pericardium) No angiographic evidence in 10-20% ECHO (Not needed in 50% at Beaumont) Delayed tamponade common (wire induced & IIbIIIa)

Management of Coronary Perforation Hemodynamic Support Volume and inotropes Pericardiocentesis (pigtail) IABP (to resussitate) Seal Perforation Reverse heparin Balloon occlusion Platelets (abciximab) Embolization (coil, gel foam, thrombus) Covered stent (Jomed available) Surgery

Stent Misadventures Imprecise placement Stent entrapment in uncrossable lesion Unexpandable lesion Sheared off by guide catheter Lost!

Common Mechanism of Stent Loss Stent Entrapment Brilakis et al CCI 2005;66:33

Mechanism of Stent Loss Stent “Pulled-Off” the Delivery Balloon Brilakis et al CCI 2005;66:33

Attempt to snare the stent or grasp it with forceps Use twisted wires What Are The Options ? Insert a balloon into the undeployed stent , inflate it and withdraw the stent out of the coronary Attempt to snare the stent or grasp it with forceps Use twisted wires High risk features in CARESS-IN-AMI: extensive ST elevation, new onset LBBB, previous MI, Killip class >2, or LVEF <35%

Retrieval of Stent with Loop Snare Brilakis et al CCI 2005;66:33

Twisted Wire Stent Retrieval Brilakis et al CCI 2005;66:33

Small Balloon Stent Retrieval Brilakis et al CCI 2005;66:33

A 1.5X20 Balloon Was Inserted Inflated ,and Withdrawn

A 1.5X20 Balloon Was Inserted Inflated ,and Withdrawn However the stent could not be pulled out

A 1.5X20 Balloon Was Inserted Inflated ,and Withdrawn And , wire position was suddenly lost

What Are The Options Now ? Leave it in place ? Snare it ? Grasp it with forceps ? Use twisted wires ? High risk features in CARESS-IN-AMI: extensive ST elevation, new onset LBBB, previous MI, Killip class >2, or LVEF <35%

Things You May Wish to Consider Which snare is best ? Shape and size of guide catheter ? Femoral sheath size ? Is imaging optimal ? High risk features in CARESS-IN-AMI: extensive ST elevation, new onset LBBB, previous MI, Killip class >2, or LVEF <35%

Retrieval Devices Brilakis et al CCI 2005;66:33

Final RCA Result

Stent Embolization Systemically – generally “safe” Intracoronary Deploy (if on wire) Crush (if off wire) Retrieve with snare or wrapped in parallel guide wires or on small balloon

Mayo Clinic Experience 11,773 PCI’s ● Stent loss in 0.32% ● Successful retrieval 35/38 - balloon expansion and withdrawal 45% - snare 26% - twisted wires 5% - forceps 12% Brilakis et al CCI 2005;66:33

Conclusion Complications of PCI have decreased with routine use of intracoronary stents However, perforation and stent misadventures continue to challenge the interventionalist. Attention to prevention, recognition and treatment of these complications is essential